ARCHIVES

CyberKnife Delivers 100 Percent PFS at 18.3 Month Followup

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

USC, Wisconsin Get Construction Grants Totaling $1.5 Million

March 23, 1990

Monroe Wall, Co-Discoverer Of Taxol, Camptothecin, Dead At 85

July 12, 2002

In Brief: Terry To Leave NCI for Job As VP Of Revlon Health Care Group; NCI Tracking Source Of Breakthroughs

June 18, 1982

In Brief: GAO Probe Of Cancer Control Program Nears End; Renewal Bill Mark Up Not Before Oct. 22

October 12, 1979

Palbocicilib Doubles PFS In Phase II Trial to 20.2 Months

April 25, 2014

Canadian Products Anticancer Drugs In Plant Culture

April 22, 1983